Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › E2F as a target of hormone refractory prostate cancer

E2F as a target of hormone refractory prostate cancer

US Patent 8822421 · Granted Sep 2, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Strategies to enhance lung cancer treatment2024
Strategies to enhance lung cancer treatment2024
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Use of multi-frequency impedance cytometry in conjunction with machine learning 2023
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Therapeutic catechols2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Specific delivery of toxins conjugated with antibodies to activate matripase2017
System and method for generating three-dimensional images from two-dimensional b2016
Nanotechnology approach for inhalation therapies2016
Nanotechnology approach for inhalation therapies2016